“ We need to try and make sure that we are following the science [on COVID-19 vaccines] very closely, and refrain from getting lost in all the… ”
In Conversation
“ The challenge for the future of innovation in Switzerland and for Swiss pharma companies in general is to once again adapt to technological changes ”
“ Whereas previously vaccines were a little out of fashion, and the sector was rather dusty and forgotten, now, people can see the importance of vaccine R&D… ”
Jon Amund Kyte – Head, Department of Experimental Cancer Treatment, OUH Comprehensive Cancer Center, Oslo University Hospital, Norway
“ [Norway] should stop thinking that we should only be the best in the world at oil and gas. We should do as they have done in… ”
“ In 2019 Switzerland exported more to the US than to France, Italy, UK and Austria combined and twice as much as Brazil, Russia, India and China… ”
“ Norway has unfulfilled innovation potential. There is a lot to be gained from an environment where pharmaceutical companies, research groups and clinicians can interact ”
“ We are trying to do fund both open research, where it is the researchers who define the research questions, as well as areas where we see… ”
Ken-ichiro Hata – Representative Director & Chairperson, Forum for Innovative Regenerative Medicine (FIRM), Japan
“ We are confident that 2020 and 2021 will be very relevant years for regenerative medicine in Japan ”
Muhammad Ali Pate – Global Director for Health, Nutrition and Population; Director, Global Financing Facility for Women, Children & Adolescents, World Bank
“ Improving health financing resilience will be critical for achieving universal healthcare, particularly if countries are hit by second or third waves of COVID-19 ”
“ The big picture trends of ageing populations and rising affluence, which lead to greater demand for specialty care products, are universal and, if anything, are moving… ”
“ All of our previous learnings and experiences around partnerships, engagement and community outreach from our efforts in HIV, HBV, and HCV have become critical as we… ”
“ We were the first Korean biotech to have independently developed, commercialized, marketed and exported an innovative drug ”